| 000 | 01759 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516015011.0 | ||
| 264 | 0 | _c20110307 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1554-6578 | ||
| 024 | 7 |
_a10.1097/NEN.0b013e31820428fa _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDamme, Markus | |
| 245 | 0 | 0 |
_aCerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis. _h[electronic resource] |
| 260 |
_bJournal of neuropathology and experimental neurology _cJan 2011 |
||
| 300 |
_a83-94 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCerebellum _xenzymology |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnzyme Replacement Therapy _xmethods |
| 650 | 0 | 4 | _aGene Targeting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLameness, Animal _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMice, Neurologic Mutants |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aalpha-Mannosidase _xdeficiency |
| 650 | 0 | 4 |
_aalpha-Mannosidosis _xdrug therapy |
| 700 | 1 | _aStroobants, Stijn | |
| 700 | 1 | _aWalkley, Steven U | |
| 700 | 1 | _aLüllmann-Rauch, Renate | |
| 700 | 1 | _aD'Hooge, Rudi | |
| 700 | 1 | _aFogh, Jens | |
| 700 | 1 | _aSaftig, Paul | |
| 700 | 1 | _aLübke, Torben | |
| 700 | 1 | _aBlanz, Judith | |
| 773 | 0 |
_tJournal of neuropathology and experimental neurology _gvol. 70 _gno. 1 _gp. 83-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/NEN.0b013e31820428fa _zAvailable from publisher's website |
| 999 |
_c20446783 _d20446783 |
||